Literature DB >> 11179348

Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling.

B Lucas1, D Bumann, A Walduck, J Koesling, L Develioglu, T F Meyer, T Aebischer.   

Abstract

Protection in the murine model of Helicobacter pylori infection may be mediated by CD4+ T cells, but the mechanism remains unclear. To better understand how protection occurs in this model, we generated and characterized H. pylori urease-specific CD4+ T cells from BALB/c mice immunized with Salmonella enterica serovar Typhimurium expressing H. pylori urease (subunits A and B). The CD4+ T cells were found to be specific for subunit A (UreA). Upon antigen-specific stimulation, expression of interleukin 4 (IL-4), IL-10, gamma interferon (IFN-gamma), and tumor necrosis factor alpha was induced. Immunocytochemical analysis showed that the majority of cells produced IFN-gamma and IL-10. Adoptive transfer of the UreA-specific CD4+ T cells into naive syngeneic recipients led to a threefold reduction in the number of bacteria in the recipient group when compared to that in the nonrecipient group. Stomach colonization was also reduced significantly after transfer of these cells into patently infected mice. Adoptive transfer of UreA-specific CD4+ T cells into IL-4 receptor alpha chain-deficient BALB/c mice indicated that IL-4 and IL-13 were not critical in the control of bacterial load. In addition, synthetic peptides were used to identify three functional T-cell epitopes present in subunit A which were recognized by the UreA-specific T cells. Analysis of H. pylori-specific cellular immune responses in recipient challenged and nonrecipient infected mice indicated a strong local restriction of the response in infected animals. The implications of these findings for the mechanism of protection and the development of peptide-based vaccination are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179348      PMCID: PMC98077          DOI: 10.1128/IAI.69.3.1714-1721.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  MHCPEP, a database of MHC-binding peptides: update 1997.

Authors:  V Brusic; G Rudy; L C Harrison
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

3.  Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets.

Authors:  R Cuenca; T G Blanchard; S J Czinn; J G Nedrud; T P Monath; C K Lee; R W Redline
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

4.  Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences.

Authors:  G E Meister; C G Roberts; J A Berzofsky; A S De Groot
Journal:  Vaccine       Date:  1995-04       Impact factor: 3.641

Review 5.  Host response and vaccine development to Helicobacter pylori infection.

Authors:  T G Blanchard; S J Czinn; J G Nedrud
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

6.  An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice.

Authors:  N Noben-Trauth; L D Shultz; F Brombacher; J F Urban; H Gu; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

7.  Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer.

Authors:  M M D'Elios; M Manghetti; F Almerigogna; A Amedei; F Costa; D Burroni; C T Baldari; S Romagnani; J L Telford; G Del Prete
Journal:  Eur J Immunol       Date:  1997-07       Impact factor: 5.532

8.  Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection.

Authors:  P Ghiara; M Rossi; M Marchetti; A Di Tommaso; C Vindigni; F Ciampolini; A Covacci; J L Telford; M T De Magistris; M Pizza; R Rappuoli; G Del Giudice
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

9.  Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load.

Authors:  M Mohammadi; J Nedrud; R Redline; N Lycke; S J Czinn
Journal:  Gastroenterology       Date:  1997-12       Impact factor: 22.682

10.  Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice.

Authors:  M Mohammadi; S Czinn; R Redline; J Nedrud
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

View more
  20 in total

Review 1.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  In vivo visualization of bacterial colonization, antigen expression, and specific T-cell induction following oral administration of live recombinant Salmonella enterica serovar Typhimurium.

Authors:  D Bumann
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

3.  Multiparameter selection of Helicobacter pylori antigens identifies two novel antigens with high protective efficacy.

Authors:  N Sabarth; R Hurwitz; T F Meyer; D Bumann
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

4.  Autodisplay: efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strains.

Authors:  Konstantin Rizos; Claus T Lattemann; Dirk Bumann; Thomas F Meyer; Toni Aebischer
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

5.  Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.

Authors:  Christine A Garhart; John G Nedrud; Frederick P Heinzel; Norma E Sigmund; Steven J Czinn
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

6.  Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent.

Authors:  Christine A Garhart; Frederick P Heinzel; Steven J Czinn; John G Nedrud
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

7.  Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunity.

Authors:  Klaus Panthel; Gerhard Faller; Rainer Haas
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

8.  Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion.

Authors:  Mark S Sundrud; Victor J Torres; Derya Unutmaz; Timothy L Cover
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

9.  Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis.

Authors:  Frank Sommer; Henning Wilken; Gerhard Faller; Michael Lohoff
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Fatty acid composition of subcutaneous adipose tissue and gastric mucosa: is there a relation with gastric ulceration?

Authors:  Vasileios A Pagkalos; Joanna Moschandreas; Michael Kiriakakis; Maria Roussomoustakaki; Anthony Kafatos; Elias Kouroumalis
Journal:  BMC Gastroenterol       Date:  2009-01-23       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.